🇺🇸 FDA
Patent

US 8575167

Spiro compounds having stearoyl-CoA desaturase action

granted A61PA61P3/00A61P3/04

Quick answer

US patent 8575167 (Spiro compounds having stearoyl-CoA desaturase action) held by Takeda Pharmaceutical Company Limited expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P3/00, A61P3/04, A61P3/06, A61P3/10